COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,732 Articles (22,502 medRxiv, 8,230 bioRxiv)

Most recent first Previous |  Page 2651: Articles 26501-26510  | Next

Seroprevalence of antibodies against SARS-CoV-2 among public community and health-care workers in Alzintan City of Libya
KAMMON, A. M., El-Arabi, A. A., Erhouma, E. A., Mehemed, T. M., Mohamed, O. A.
10.1101/2020.05.25.20109470 — Posted: 2020-05-26
BCG vaccination and socioeconomic variables vs Covid-19 global features: clearing up a controversial issue
Ventura, L., Vitali, M., Romano Spica, V.
10.1101/2020.05.20.20107755 — Posted: 2020-05-26 Discussion: Onsite
Comprehensive genome analysis of 6,000 USA SARS-CoV-2 isolates reveals haplotype signatures and localized transmission patterns by state and by country
Shen, L., Dien Bard, J., Biegel, J. A., Judkins, A. R., Gai, X.
10.1101/2020.05.23.20110452 — Posted: 2020-05-26
Prone Cardiopulmonary Resuscitation: A Rapid Scoping and Expanded Grey Literature Review for the COVID-19 Pandemic
Douma, M. J., MacKenzie, E., Loch, T., Tan, M. C., Anderson, D., Picard, C., Milovanovic, L., O'Dochartaigh, D., Brindley, P. G.
10.1101/2020.05.21.20109710 — Posted: 2020-05-26
Estimating effective reproduction number using generation time versus serial interval, with application to COVID-19 in the Greater Toronto Area, Canada
Knight, J., Mishra, S.
10.1101/2020.05.24.20109215 — Posted: 2020-05-26 Discussion: Onsite
Knowledge, attitude, and practices of Community pharmacists about COVID-19: A cross-sectional survey in two provinces of Pakistan.
Muhammad, K., Saqlain, M., Hamdard, A., Naveed, M., Umer, M. F., Khan, S., Kamran, M., Rashid, H., Kamran, S., Khan, M. I., Khan, F. U., Hussain, Y., Khan, Z.
10.1101/2020.05.22.20108290 — Posted: 2020-05-26
Syndromic Surveillance for COVID-19 in Canada
Lapointe-Shaw, L., Rader, B., Astley, C. M., Hawkins, J. B., Bhatia, D., Schatten, W. J., Lee, T. C., Liu, J. J., Ivers, N. M., Stall, N. M., Gournis, E., Tuite, A. R., Fisman, D. N., Bogoch, I. I., Brownstein, J. S.
10.1101/2020.05.19.20107391 — Posted: 2020-05-26
Impaired T cell functions along with elevated activated Tregs at the early stage of asymptomatic SARS-CoV-2 infection
Yang, J., Zhang, E., Zhong, M., Yang, Q., Hong, K., Shu, T., Zhou, D., Xiang, J., Xia, J., Zhou, X., Zhang, D., Huang, C., Shang, Y., Yan, H.
10.1101/2020.05.25.20108852 — Posted: 2020-05-26 Discussion: Onsite | Offsite
A benchmark of online COVID-19 symptom checkers
Munsch, N., Martin, A., Gruarin, S., Nateqi, J., Abdarahmane, I., Weingartner-Ortner, R., Knapp, B.
10.1101/2020.05.22.20109777 — Posted: 2020-05-26
Use of High Flow Nasal Therapy to Treat Moderate to Severe Hypoxemic Respiratory Failure in COVID-19
Patel, M., Gangemi, A., Marron, R., Chowdhury, J., Yousef, I., Zheng, M., Mills, N., Tragesser, L., Giurintano, J., Gupta, R., Gordon, M., Rali, P., D'Alonzo, G., Fleece, D., Zhao, H., Patlakh, N., Criner, G. J.
10.1101/2020.05.22.20109355 — Posted: 2020-05-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).